Implantable orthotopic bladder cancer model in Wistar rats: A pilot and feasibility study

1. Tae BS, Jeong CW, Kwak C, Kim HH, Moon KC, Ku JH. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer. PloS one. 2017;12(12):e0189354. DOI: 10.1371/journal.pone.018935410.1371/journal.pone.0189354573173529244843Search in Google Scholar

2. Zhou N, Singh K, Mir MC, Parker Y, Lindner D, Dreicer R, et al. The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo. Clin Cancer Res. 2013;19(7):1717-28. DOI: 10.1158/1078-0432.CCR-12-238310.1158/1078-0432.CCR-12-2383362629123403633Open DOISearch in Google Scholar

3. Xiao Z, McCallum TJ, Brown KM, Miller GG, Halls SB, Parney I, et al. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer. 1999;81(4):638-46. DOI: 10.1038/sj.bjc.669074110.1038/sj.bjc.6690741236288710574249Open DOISearch in Google Scholar

4. Arentsen HC, Hendricksen K, Oosterwijk E, Witjes JA. Experimental rat bladder urothelial cell carcinoma models. World J Urol. 2009;27(3):313-7. DOI: 10.1007/s00345-009-0381-510.1007/s00345-009-0381-5269431219219611Open DOISearch in Google Scholar

5. Teke K, Guzel N, Uslubas AK, Kasap M, Yilmaz H, Akpinar G, et al. Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model. Cancer Immunol Immunother. 2018;67(1):67-77. DOI: 10.1007/s00262-017-2063-210.1007/s00262-017-2063-228916862Open DOISearch in Google Scholar

6. Teke K, Ozkan TA, Cebeci OO, Yilmaz H, Keles ME, Ozkan L, et al. Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats. Exp Anim. 2017;66(3):191-8. DOI: 10.1538/expanim.16-009310.1538/expanim.16-0093554323928228618Search in Google Scholar

7. Reis LO, Favaro WJ, Ferreira U, Billis A, Fazuoli MG, Cagnon VH. Evolution on experimental animal model for upper urothelium carcinogenesis. World J Urol. 2010;28(4):499-505. DOI: 10.1007/s00345-010-0545-310.1007/s00345-010-0545-320373103Open DOISearch in Google Scholar

8. Reis LO, Ferrari K, Zamuner M, Rocha GZ, Billis A, Favaro WJ. Urothelial carcinogen resistance driven by stronger Toll-like receptor 2 (TLR2) and Uroplakin III (UP III) defense mechanisms: a new model. World J Urol. 2015 Mar;33(3):413-9. DOI: 10.1007/s00345-014-1329-y10.1007/s00345-014-1329-y24871424Open DOISearch in Google Scholar

9. Franco NH. Animal Experiments in Biomedical Research: A Historical Perspective. Animals (Basel). 2013;3(1):238-73. DOI: 10.3390/ani301023810.3390/ani3010238449550926487317Open DOISearch in Google Scholar

10. Satoh H, Morimoto Y, Arai T, Asanuma H, Kawauchi S, Seguchi K, et al. Intravesical ultrasonography for tumor staging in an orthotopically implanted rat model of bladder cancer. J Urol. 2007;177(3):1169-73. DOI: 10.1016/j.juro.2006.10.03810.1016/j.juro.2006.10.03817296439Search in Google Scholar

11. Montironi R, Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol. 2005;13(2):143-53. DOI: 10.1177/10668969050130020310.1177/10668969050130020315864376Open DOISearch in Google Scholar

12. van Moorselaar RJ, Ichikawa T, Schaafsma HE, Jap PH, Isaacs JT, van Stratum P, et al. The rat bladder tumor model system RBT resembles phenotypically and cytogenetically human superficial transitional cell carcinoma. Urol Res. 1993;21(6):413-21. DOI: 10.1007/BF0030007810.1007/BF003000788171764Open DOISearch in Google Scholar

13. Bisson JF, Parache RM, Droulle P, Notter D, Vigneron C, Guillemin F. A new method of implanting orthotopic rat bladder tumor for experimental therapies. Int J Cancer. 2002;102(3):280-5. DOI: 10.1002/ijc.1059510.1002/ijc.1059512397652Open DOISearch in Google Scholar

14. Hendricksen K, Molkenboer-Kuenen J, Oosterwijk E, Hulsbergen-van de Kaa CA, Witjes JA. Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy. BJU Int. 2008;101(7):889-93. DOI: 10.1111/j.1464-410X.2007.07407.x10.1111/j.1464-410X.2007.07407.x18201266Open DOISearch in Google Scholar

15. Arentsen HC, Hendricksen K, Hulsbergen-van de Kaa CA, Reddy G, Oosterwijk E, Alfred Witjes J. The orthotopic Fischer/AY-27 rat bladder urothelial cell carcinoma model to test the efficacy of different apaziquone formulations. Urol Oncol. 2012;30(1):64-8. DOI: 10.1016/j.urolonc.2009.10.00210.1016/j.urolonc.2009.10.00219945311Search in Google Scholar

16. John BA, Said N. Insights from animal models of bladder cancer: recent advances, challenges, and opportunities. Oncotarget. 2017;8(34):57766-81. DOI: 10.18632/oncotarget.1771410.18632/oncotarget.17714559368228915710Search in Google Scholar

17. Ohana P, Gofrit O, Ayesh S, Al-Sharef W, Mizrahi A, Birman T, et al. Regulatory sequences of the H19 gene in DNA based therapy of bladder. Gene Ther Mol Biol. 2004;(8):181–92Search in Google Scholar

18. Chade DC, Andrade PM, Borra RC, Leite KR, Andrade E, Villanova FE, et al. Histopathological characterization of a syngeneic orthotopic murine bladder cancer model. Int Braz J Urol. 2008;34(2):220-6; discussion 6-9. DOI: 10.1590/S1677-5538200800020001310.1590/S1677-5538200800020001318462521Open DOISearch in Google Scholar